SWOT analysis: strengths, weaknesses, opportunities and threats of the Israeli Smallpox Revaccination Program.
During September 2002, Israel began its current revaccination program against smallpox, targeting previously vaccinated "first responders" among medical and emergency workers. In order to identify the potential strengths and weaknesses of this program and the conditions under which critical decisions were reached, we conducted a SWOT analysis of the current Israeli revaccination program, designed to identify its intrinsic strengths and weaknesses, as well as opportunities for its success and threats against it. SWOT analysis--a practical tool for the study of public health policy decisions and the social and political contexts in which they are reached--revealed clear and substantial strengths and weaknesses of the current smallpox revaccination program, intrinsic to the vaccine itself. A number of threats were identified that may jeopardize the success of the current program, chief among them the appearance of severe complications of vaccination. Our finding of a lack of a generation of knowledge on smallpox vaccination highlights the need for improved physician education and dissipation of misconceptions that are prevalent in the public today.
Huerta
Michael
M
Israel Defense Force Medical Corps, Army Health Branch, Tel Hashomer, Israel.
Balicer
Ran D
RD
Leventhal
Alex
A
D000075202:Contraindications; D006291:Health Policy; D006801:Humans; D017589:Immunization Programs / Q000592:standards*; D007493:Iraq; D007557:Israel; D015397:Program Evaluation; D012307:Risk Factors; D012900:Smallpox Vaccine / Q000008:administration & dosage* / Q000009:adverse effects / Q000600:supply & distribution; D013678:Technology, Pharmaceutical / Q000592:standards; D023481:Terrorism; D014611:Vaccination / Q000009:adverse effects / Q000592:standards*; D014857:Warfare
D012900:Smallpox Vaccine